FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W88046986> ?p ?o ?g. }

• W88046986 endingPage "1486" @default.
• W88046986 startingPage "1477" @default.
• W88046986 abstract "The infusion of lymphocytes from the original marrow donor (donor lymphocyte infusion [DLI]) reinduces complete remission in a high percentage of patients with chronic myeloid leukemia (CML) who relapse after allogeneic stem cell transplant, and thus, is probably the best initial approach to their management. The major predictive factor for response is the disease stage at time of treatment, because patients in molecular or cytogenetic relapse fare better than those in hematologic relapse. Moreover, patients with a short interval between transplant and DLI have a higher probability of response than those with longer intervals. The durability of DLI-induced remissions has not yet been established, but they appear to be prolonged. The observation that DLI can be highly effective for patients in relapse has encouraged the recent development of new strategies designed to minimize the myeloablative regimen and exploit the immunotherapeutic component of the transplant. The principal complication associated with use of DLI is the occurrence of graft-versus-host disease (GVHD). Several approaches have been tested to reduce the incidence or impact of GVHD, based on the ex vivo depletion of alloreactive donor cells or the use of donor T cells transduced with a suicide gene. The incidence of GVHD can also be reduced by starting with low doses of donor cells and “escalating” subsequent doses as required. However, the identification of selective targets for leukemia-reactive immunity is probably the optimal strategy to resolve the problem of GVHD. Although currently minor histocompatibility antigens appear to be the most likely targets for DLI, several groups are focusing on the generation of leukemia-specific immunity. The results obtained by use of tumor-associated antigens presented by dendritic cells are encouraging and may lay the foundations for the use of adoptive immunotherapy in the autologous setting." @default.
• W88046986 created "2016-06-24" @default.
• W88046986 creator A5020401806 @default.
• W88046986 creator A5039305143 @default.
• W88046986 creator A5061733081 @default.
• W88046986 date "1999-10-01" @default.
• W88046986 modified "2023-10-18" @default.
• W88046986 title "Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant" @default.
• W88046986 cites W106695551 @default.
• W88046986 cites W151799953 @default.
• W88046986 cites W1545991364 @default.
• W88046986 cites W1558238582 @default.
• W88046986 cites W1663208787 @default.
• W88046986 cites W1707184873 @default.
• W88046986 cites W175951554 @default.
• W88046986 cites W1848072063 @default.
• W88046986 cites W1873141201 @default.
• W88046986 cites W1883328448 @default.
• W88046986 cites W1912762949 @default.
• W88046986 cites W1965119257 @default.
• W88046986 cites W1969715308 @default.
• W88046986 cites W1972298297 @default.
• W88046986 cites W1983075214 @default.
• W88046986 cites W1987746867 @default.
• W88046986 cites W1989064979 @default.
• W88046986 cites W1991171923 @default.
• W88046986 cites W1995133626 @default.
• W88046986 cites W1997398245 @default.
• W88046986 cites W1998214675 @default.
• W88046986 cites W2000816527 @default.
• W88046986 cites W2005037046 @default.
• W88046986 cites W2006987944 @default.
• W88046986 cites W2013235252 @default.
• W88046986 cites W2022861083 @default.
• W88046986 cites W2025383600 @default.
• W88046986 cites W2028207500 @default.
• W88046986 cites W2032577452 @default.
• W88046986 cites W2036694049 @default.
• W88046986 cites W2040654275 @default.
• W88046986 cites W2041758085 @default.
• W88046986 cites W2048435376 @default.
• W88046986 cites W2050253058 @default.
• W88046986 cites W2058053814 @default.
• W88046986 cites W2058809104 @default.
• W88046986 cites W2071415293 @default.
• W88046986 cites W2071989019 @default.
• W88046986 cites W2072246943 @default.
• W88046986 cites W2087013294 @default.
• W88046986 cites W2090177390 @default.
• W88046986 cites W2095220820 @default.
• W88046986 cites W2101065496 @default.
• W88046986 cites W2102236034 @default.
• W88046986 cites W2105199004 @default.
• W88046986 cites W2112041130 @default.
• W88046986 cites W2122918559 @default.
• W88046986 cites W2138913424 @default.
• W88046986 cites W2167541030 @default.
• W88046986 cites W2196875085 @default.
• W88046986 cites W2255034921 @default.
• W88046986 cites W2262568580 @default.
• W88046986 cites W2297816245 @default.
• W88046986 cites W2321645223 @default.
• W88046986 cites W2335166576 @default.
• W88046986 cites W2336061803 @default.
• W88046986 cites W2340547456 @default.
• W88046986 cites W2400663726 @default.
• W88046986 cites W2401486119 @default.
• W88046986 cites W2403312252 @default.
• W88046986 cites W2405000242 @default.
• W88046986 cites W2406270628 @default.
• W88046986 cites W2416148102 @default.
• W88046986 cites W2416716216 @default.
• W88046986 cites W2418889500 @default.
• W88046986 cites W2508058084 @default.
• W88046986 cites W287390018 @default.
• W88046986 cites W3112353337 @default.
• W88046986 cites W319578897 @default.
• W88046986 cites W4237274532 @default.
• W88046986 cites W4245114051 @default.
• W88046986 cites W4246085869 @default.
• W88046986 cites W44995847 @default.
• W88046986 cites W53690666 @default.
• W88046986 cites W6098476 @default.
• W88046986 doi "https://doi.org/10.1016/s0301-472x(99)00096-x" @default.
• W88046986 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10517488" @default.
• W88046986 hasPublicationYear "1999" @default.
• W88046986 type Work @default.
• W88046986 sameAs 88046986 @default.
• W88046986 citedByCount "123" @default.
• W88046986 countsByYear W880469862012 @default.
• W88046986 countsByYear W880469862013 @default.
• W88046986 countsByYear W880469862014 @default.
• W88046986 countsByYear W880469862015 @default.
• W88046986 countsByYear W880469862017 @default.
• W88046986 countsByYear W880469862018 @default.
• W88046986 countsByYear W880469862020 @default.
• W88046986 countsByYear W880469862022 @default.
• W88046986 crossrefType "journal-article" @default.

• next